ARCHIVES

Phase II ThermoDox Trial Demonstrates Positive Response

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

Finasteride Cut Risk Of Prostate Cancer In Large Trial, But Value In Clinic Unclear.

June 27, 2003

Wyden, Schroeder Bill Would Require NIH To Test RU 486

October 23, 1992

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

July 17, 2009

FDA Adopts Plan For Drug Approval After Phase 2; Chabner Unconvinced

November 4, 1988

Karmanos Cancer Institute, CDC, Blue Cross To Begin Environmental Cancer Program

June 4, 2010

Patient Satisfaction Was Crucial In ODAC Review Of Panretin

November 27, 1998